Biomedical Engineering Reference
In-Depth Information
86. Kirker-Head CA, Nevins M, Palmer R et al. A new animal model for maxillary sinus floor aug-
mentation: Evaluation parameters. Int J Oral Maxillofac Implants 1997; 12:403-11.
87. Yudell RM, Block MS. Bone gap healing in the dog using recombinant human bone morphoge-
netic protein-2. J Oral Maxillofac Surg 2000; 58:761-6.
88. Boyne PJ. Application of bone morphogenetic proteins in the treatment of clinical oral and maxil-
lofacial osseous defects. J Bone Joint Surg Am 2001; 83-A:S146-50.
89. Hecht BP, Fischgrund JS, Herkowitz HN et al. The use of recombinant human bone morphoge-
netic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody
fusion model. Spine 1999; 24:629-36.
90. Boden SD, Zdeblick TA, Sandhu HS et al. The use of rhBMP-2 in interbody fusion cages. Defini-
tive evidence of osteoinduction in humans: A preliminary report. Spine 2000; 25:376-81.
91. Friedlaender GE, Perry CR, Cole JD et al. Osteogenic protein-1 (bone morphogenetic protein-7)
in the treatment of tibial nonunions. J Bone Joint Surg Am 2001; 83-A:S151-8.
92. Friess W, Uludag H, Foskett S et al. Characterization of absorbable collagen sponges as rhBMP-2
carriers. Int J Pharm 1999; 187:91-9.
93. Winn S, Uludag H, Hollinger JO. Sustained release emphasizing recombinant human bone mor-
phogenetic protein-2. Adv Drug Deliv Rev 1998; 31:303-318
94. Yamamoto M, Ikada Y, Tabata Y. Controlled release of growth factors based on biodegradation of
gelatin hydrogel. J Biomater Sci Polym Ed 2001; 12:77-88
95. Hong L, Tabata Y, Yamamoto M et al. Comparison of bone regeneration in a rabbit skull defect
by recombinant human BMP-2 incorporated in biodegradable hydrogel and in solution. J Biomater
Sci Polym Ed 1998; 9:1001-14.
96. Hong L, Tabata Y, Miyamoto S et al. Bone regeneration at rabbit skull defects treated with trans-
forming growth factor-beta1 incorporated into hydrogels with different levels of biodegradability. J
Neurosurg 2000; 92:315-25.
97. Rao KP. Recent developments of collagen-based materials for medical applications and drug deliv-
ery systems. J Biomater Sci Polym Ed 1995; 7:623-45.
98. Toole B. Proteoglycans and hyaluronan in morphogenesis and differentiation. Hay E, ed. New-York:
Plenum Press, 1991:305-341.
99. Kim HD, Valentini RF. Retention and activity of BMP-2 in hyaluronic acid-based scaffolds in
vitro. J Biomed Mater Res 2002; 59:573-584
100. Bulpitt P, Aeschlimann D. New strategy for chemical modification of hyaluronic acid: Preparation
of functionalized derivatives and their use in the formation of novel biocompatible hydrogels. J
Biomed Mater Res 1999; 47:152-69.
101. Hunt DR, Jovanovic SA, Wikesjo UM et al. Hyaluronan supports recombinant human bone mor-
phogenetic protein-2 induced bone reconstruction of advanced alveolar ridge defects in dogs. A
pilot study. J Periodontol 2001; 72:651-8.
102. Martinowitz U, Saltz R. Fibrin sealant. Curr Opin Hematol 1996; 3:395-402.
103. Kawamura M, Urist MR. Human fibrin is a physiologic delivery system for bone morphogenetic
protein. Clin Orthop 1988; 302-10.
104. Mackenzie DJ, Sipe R, Buck D et al. Recombinant human acidic fibroblast growth factor and
fibrin carrier regenerates bone. Plast Reconstr Surg 2001; 107:989-96.
105. Langer R. New methods of drug delivery. Science 1990; 249:1527-1533.
106. Folkman J, Long DM. The use of silicone rubber as a carrier for prolonged drug therapy. J Surg
Res 1964; 4:139.
107. Langer R. 1994 Whitaker Lecture: Polymers for drug delivery and tissue engineering. Ann Biomed
Eng 1995; 23:101-11.
108. Chu CC. The degradation and biocompatibility of suture materials. Williams DF, ed. Boca Raton,
FL: 1985:261-322.
109. Kulkarni RK, Moore EG, Hegyeli AF et al. Biodegradable poly(lactic acid) polymers. J Biomed
Mater Res 1971; 5:169-81.
110. Domb AJ, Amselem S, Maniar M. Biodegradable polymers as drug carrier systems. Dumitriu S,
ed. New York: Marcel Dekker, Inc.,1994:399-433.
111. Hollinger JO, Leong K. Poly(alpha-hydroxy acids): Carriers for bone morphogenetic proteins.
Biomaterials 1996; 17:187-94.
112. Vert M, Li S, Garreau H. New insights on the degradation of bioresorbable polymeric devices
based on lactic and glycolic acids. Clin Mater 1992; 10:3-8
113. Hollinger JO, Brekke J, Gruskin E et al. Role of bone substitutes. Clin Orthop 1996; 55-65.
114. Vert M, Chabot F, Leray J et al. Biodegradable polyesters for bone surgery. Makromol Chem
Suppl 1981; 5:30-36.
Search WWH ::
Custom Search